No company is going on the record to invest in BIT at the end of phase 2 trials. Why would the big pharm companies invest their hard earned cash until phase 3 trials pan out when the stockholders are paying for it? But if you believe in BIT and the 1.1 million people in the US who are HIV positive and have the health insurance to pay for a cure. And let’s not forget the hepatitis implications of this study. My simple minded take.
No company is going on the record to invest in BIT at the end of...
-
- There are more pages in this discussion • 380 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
